Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Hadjigeorgiou

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Sleep Research|September 26, 2018
Sleep and subjective cognitive decline in cognitively healthy elderly: Results from two cohortsAngeliki Tsapanou, Georgios S Vlachos, Stephanie Cosentino, et al.
The Journal of Nutritional Biochemistry|March 28, 2022
Dietary Inflammatory Index score and prodromal Parkinson's disease incidence: The HELIAD studyVassilis Balomenos, Lamprini Bounou, Sokratis Charisis, et al.
Journal of Neurology|September 17, 2009
Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center studyBirgit Högl, Diego García-Borreguero, Ralf Kohnen, et al.
Biomedicines|May 25, 2024
Cerebral Amyloidosis in Individuals with Subjective Cognitive Decline: From Genetic Predisposition to Actual Cerebrospinal Fluid MeasurementsStefanos N Sampatakakis, Niki Mourtzi, Sokratis Charisis, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Genetic predisposition to high circulating levels of interleukin 6 and risk for Alzheimer's disease. Discovery and replicationSokratis Charisis, Niki Mourtzi, Matthew R Scott, et al.
European Journal of Ageing|February 25, 2025
The potential of depressive symptoms to identify cognitive impairment in ageingPanagiotis Alexopoulos, Christos Bountoulis, Everina Katirtzoglou, et al.
Plos One|November 25, 2014
Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2014
Alpha-synuclein repeat variants and survival in Parkinson's diseaseSun Ju Chung, Joanna M Biernacka, Sebastian M Armasu, et al.
JAMA|August 10, 2006
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson diseaseDemetrius M Maraganore, Mariza de Andrade, Alexis Elbaz, et al.
Annals of Neurology|September 27, 2018
Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhageGeorgios Tsivgoulis, Duncan Wilson, Aristeidis H Katsanos, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Sleep Research|September 26, 2018
Sleep and subjective cognitive decline in cognitively healthy elderly: Results from two cohortsAngeliki Tsapanou, Georgios S Vlachos, Stephanie Cosentino, et al.
The Journal of Nutritional Biochemistry|March 28, 2022
Dietary Inflammatory Index score and prodromal Parkinson's disease incidence: The HELIAD studyVassilis Balomenos, Lamprini Bounou, Sokratis Charisis, et al.
Journal of Neurology|September 17, 2009
Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center studyBirgit Högl, Diego García-Borreguero, Ralf Kohnen, et al.
Biomedicines|May 25, 2024
Cerebral Amyloidosis in Individuals with Subjective Cognitive Decline: From Genetic Predisposition to Actual Cerebrospinal Fluid MeasurementsStefanos N Sampatakakis, Niki Mourtzi, Sokratis Charisis, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Genetic predisposition to high circulating levels of interleukin 6 and risk for Alzheimer's disease. Discovery and replicationSokratis Charisis, Niki Mourtzi, Matthew R Scott, et al.
European Journal of Ageing|February 25, 2025
The potential of depressive symptoms to identify cognitive impairment in ageingPanagiotis Alexopoulos, Christos Bountoulis, Everina Katirtzoglou, et al.
Plos One|November 25, 2014
Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2014
Alpha-synuclein repeat variants and survival in Parkinson's diseaseSun Ju Chung, Joanna M Biernacka, Sebastian M Armasu, et al.
JAMA|August 10, 2006
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson diseaseDemetrius M Maraganore, Mariza de Andrade, Alexis Elbaz, et al.
Annals of Neurology|September 27, 2018
Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhageGeorgios Tsivgoulis, Duncan Wilson, Aristeidis H Katsanos, et al.
Pageof 11